OralDosed ingredient Cosmetic cross-reference

Magnesium Oxide

CAS 1309-48-4

Magnesium Oxide (CAS 1309-48-4) is a Phase 4 pharmaceutical compound with 0 bioactivity targets and 6,099 adverse event associations.

SOURCE NLM DailyMed
Label records
0
SOURCE EMBL-EBI ChEMBL
Bioactivity
0
SOURCE DrugCentral
Adverse signals
6,099
SOURCE IUPHAR/BPS
PubMed IDs
0
SOURCE EMBL-EBI ChEMBL B25820EEF0F0

Compound Identity

Matched identifiers and naming fields for the pharmaceutical compound record.

Primary Name
Magnesium Oxide
CAS Number
1309-48-4
UNII
3A3U0GI71G
InChIKey
CPLXHLVBOLITMK-UHFFFAOYSA-N
ChEMBL ID
CHEMBL1200572
Molecule Type
Small molecule
Source Match
EMBL-EBI ChEMBL (INCHIKEY)
dosed ingredientnatural productoral
SOURCE EMBL-EBI ChEMBL B25820EEF0F0

Clinical Development Phase

Highest clinical development phase rendered from the matched compound identifier rows.

Phase 4 (Approved)
Approved or marketed human pharmaceutical use is represented in the source phase field.
ChEMBL CHEMBL1200572 | Small molecule
SOURCE Ingredients table / CosIng profile same-CAS cross-reference

Cross-Reference to Cosmetics

Same-CAS ingredient record found in the cosmetics vertical.

This substance also has a cosmetic safety profile →
SOURCE DrugCentral 80 associations

Adverse Event Associations

DrugCentral / FAERS disproportionality signal rows matched to this compound.

Reaction PTDrug AE LLRMedDRA
Pemphigus 5390 2478.727 10034280
Systemic lupus erythematosus 5724 2390.371 10042945
Glossodynia 4957 2089.117 10018388
Hand deformity 4329 1757.556 10061194
Arthropathy 5543 1585.85 10003285
Rheumatoid arthritis 5902 1559.172 10039073
Toxicity to various agents 1011 1502.321 10070863
Alopecia 6727 1477.341 10001760
Wound 4181 1416.904 10052428
Abdominal discomfort 6829 1407.882 10000059
Maternal exposure during pregnancy 4769 1387.649 10071408
Completed suicide 216 1305.582 10010144
Synovitis 4260 1213.691 10042868
Contraindicated product administered 4767 1090.424 10078504
Anti-cyclic citrullinated peptide antibody positive 2939 1087.675 10068798
Infusion related reaction 5513 1043.273 10051792
Joint swelling 6316 1020.643 10023232
Pericarditis 3244 1018.717 10034484
Swelling 5457 1013.184 10042674
Discomfort 3789 998.242 10013082
Drug abuse 125 972.816 10013654
Pain 12070 891.7 10033371
Drug interaction 1639 813.688 10013710
Death 3691 808.204 10011906
Arthralgia 9596 696.643 10003239
Duodenal ulcer perforation 2096 687.437 10013849
Rheumatoid factor positive 1987 670.52 10039080
Helicobacter infection 2164 662.183 10054263
Exposure during pregnancy 3030 604.715 10073513
Intentional overdose 141 588.767 10022523
Hepatic enzyme increased 3889 587.846 10060795
Psoriatic arthropathy 2183 567.318 10037162
Product use issue 4452 545.113 10076309
Musculoskeletal stiffness 3619 525.411 10052904
Drug intolerance 5225 495.968 10061822
Therapeutic product effect decreased 3502 445.743 10082201
Acute kidney injury 2930 427.665 10069339
Overdose 756 417.625 10033295
Nasopharyngitis 4362 369.328 10028810
Knee arthroplasty 1254 349.988 10023469
Suicide attempt 202 346.23 10042464
Hip arthroplasty 1116 329.925 10020096
Treatment failure 3535 318.741 10066901
Rheumatic fever 969 299.035 10039054
Disease progression 1064 295.024 10061818
Foetal exposure during pregnancy 1812 295.011 10071404
Impaired healing 1904 290.477 10021519
Hypersensitivity 4516 283.511 10020751
Cardiac arrest 721 279.016 10007515
Muscle injury 1267 268.746 10028314

Association rows are source-linked signal records, not incidence rates or clinical causality claims.

SOURCE NLM RxNorm 4 name rows

Drug Names / RxNorm

Normalized drug-name vocabulary rows, RxCUIs, and source abbreviations.

NameRxCUI TypeSource
MAGNESIUM OXIDE 6582 SU MTHSPL
Magnesium Oxide 6582 SU MTHSPL
magnesium oxide 6582 SU MTHSPL
magnesium oxide 6582 IN RXNORM
SOURCE Rendered pharma page rows FAQPage JSON-LD

Frequently Asked Questions

Short answers generated only from the same visible source-linked rows on this page.

What is Magnesium Oxide used for in pharmaceutical contexts?

Magnesium Oxide (CAS 1309-48-4) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.

What are the known adverse events for Magnesium Oxide?

Magnesium Oxide has 6,099 DrugCentral/FAERS adverse event associations. Rendered reaction terms include Pemphigus, Systemic lupus erythematosus, Glossodynia, Hand deformity, Arthropathy. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.

Is Magnesium Oxide also used in cosmetics?

Yes. The ingredients table has a same-CAS cosmetic profile for Magnesium Oxide with EU status "permitted".

What clinical phase is Magnesium Oxide in?

Magnesium Oxide is rendered with ChEMBL max phase 4 (approved).